Skip to main content
. Author manuscript; available in PMC: 2019 Oct 25.
Published in final edited form as: Obesity (Silver Spring). 2019 Apr 25;27(6):997–1004. doi: 10.1002/oby.22458

Table 1.

Characteristics of B-SCANS study population stratified by quartiles of subcutaneous fat and visceral fat.

Quartiles of Subcutaneous Adipose Tissue (cm2) Quartiles of Visceral Adipose Tissue (cm2)
Category boundaries [19, 160] (160, 238] (238, 336] (336, 891] [0.484, 43.2] (43.2, 94.6] (94.6, 163] (163, 454] Total
N 854 897 790 694 952 845 808 630 3,235
Deaths 177 177 177 177 177 177 177 177 708
Age [mean (sd)] 52.20 (12.95) 54.42 (11.98) 54.72 (10.82) 55.29 (10.86) 48.63 (11.62) 53.37 (11.28) 56.62 (10.74) 60.09 (10.15) 54.1 (11.8)
Race
White/non-Hispanic 627 (74.2) 615 (69.3) 559 (71.7) 476 (69.3) 696 (74.0) 573 (68.3) 518 (65.2) 490 (78.4) 2,277 (71.2)
Black 30 ( 3.6) 50 ( 5.6) 50 ( 6.4) 100 (14.6) 57 ( 6.1) 70 ( 8.3) 72 ( 9.1) 31 ( 5.0) 230 ( 7.2)
Hispanic 36 ( 4.3) 68 ( 7.7) 96 (12.3) 80 (11.6) 49 ( 5.2) 70 ( 8.3) 93 (11.7) 68 (10.9) 280 ( 8.8)
Asian/Pacific Islander 152 (18.0) 154 (17.4) 75 ( 9.6) 31 ( 4.5) 139 (14.8) 126 (15.0) 111 (14.0) 36 ( 5.8) 412 (12.9)
Other 9 10 10 7 11 6 14 5 36
Smoking Status
Never 527 (63.0) 566 (64.2) 433 (55.9) 388 (57.2) 589 (63.4) 520 (63.0) 487 (61.4) 318 (51.0) 1,914 (60.4)
Former 235 (28.1) 242 (27.5) 253 (32.6) 229 (33.8) 253 (27.2) 230 (27.9) 230 (29.0) 246 (39.5) 959 (30.3)
Current 74 ( 8.9) 73 ( 8.3) 89 (11.5) 61 ( 9.0) 87 ( 9.4) 75 ( 9.1) 76 ( 9.6) 59 ( 9.5) 297 ( 9.4)
Unknown 18 16 15 16 23 20 15 7 65
Stage
II 559 (65.5) 543 (60.5) 454 (57.5) 388 (55.9) 621 (65.2) 501 (59.3) 475 (58.8) 347 (55.1) 1,944 (60.1)
III 295 (34.5) 354 (39.5) 336 (42.5) 306 (44.1) 331 (34.8) 344 (40.7) 333 (41.2) 283 (44.9) 1,291 (39.9)
Tumor Grade
Well differentiated 88 (10.8) 82 ( 9.5) 63 ( 8.4) 68 (10.2) 82 ( 8.9) 65 ( 8.1) 88 (11.4) 66 (11.0) 301 ( 9.7)
Moderately differentiated 343 (41.9) 348 (40.5) 310 (41.1) 260 (39.0) 364 (39.4) 314 (39.2) 325 (42.2) 258 (42.9) 1,261 (40.7)
Poor/Undifferentiated 387 (47.3) 430 (50.0) 381 (50.5) 338 (50.8) 478 (51.7) 423 (52.7) 358 (46.4) 277 (46.1) 1,536 (49.6)
Unknown 36 37 36 28 28 43 37 29 137
Surgery
None 43 ( 5.0) 48 ( 5.4) 50 ( 6.3) 36 ( 5.2) 48 ( 5.0) 54 ( 6.4) 40 ( 5.0) 35 ( 5.6) 177 ( 5.5)
Lumpectomy 249 (29.2) 305 (34.0) 281 (35.6) 257 (37.0) 268 (28.2) 302 (35.7) 308 (38.1) 214 (34.0) 1,092 (33.8)
Mastectomy 562 (65.8) 544 (60.6) 459 (58.1) 401 (57.8) 636 (66.8) 489 (57.9) 460 (56.9) 381 (60.5) 1,966 (60.8)
ER/PR status
Both negative 217 (25.4) 242 (27.0) 209 (26.5) 188 (27.1) 262 (27.5) 249 (29.5) 208 (25.7) 137 (21.7) 856 (26.5)
Either positive 637 (74.6) 655 (73.0) 581 (73.5) 506 (72.9) 690 (72.5) 596 (70.5) 600 (74.3) 493 (78.3) 2,379 (73.5)
HER-2 Status
Negative 596 (69.8) 657 (73.2) 572 (72.4) 552 (79.5) 657 (69.0) 613 (72.5) 611 (75.5) 498 (79.0) 2,377 (73.5)
Positive 209 (24.5) 191 (21.3) 167 (21.1) 106 (15.3) 248 (26.1) 182 (21.5) 154 (19.0) 89 (14.1) 673 (20.8)
Equivocal 49 ( 5.7) 49 ( 5.5) 51 ( 6.5) 36 ( 5.2) 47 ( 4.9) 51 ( 6.0) 44 ( 5.4) 43 ( 6.8) 185 ( 5.7)
Muscle area in cm2 [mean (sd)] 105.24 (16.12) 110.86 (16.86) 117.95 (17.73) 129.77 (21.37) 108.28 (16.36) 111.83 (17.90) 117.65 (19.36) 126.86 (22.64) 115.17 (20.01)
BMI [mean (sd)] 22.19 (2.55) 26.01 (3.02) 29.62 (3.42) 36.57 (5.74) 22.92 (3.22) 26.69 (3.88) 30.22 (5.13) 35.35 (6.08) 28.15 (6.37)